Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pharmanutra S.p.A

PHN
Current price
54.8 EUR +0.9 EUR (+1.67%)
Last closed 53.7 EUR
ISIN IT0005274094
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Borsa Italiana
Capitalization 518 808 474 EUR
Yield for 12 month +0.92 %
1Y
3Y
5Y
10Y
15Y
PHN
21.11.2021 - 28.11.2021

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy. Address: Via Campodavela 1, Pisa, PI, Italy, 56122

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

72.41 EUR

P/E ratio

48.3036

Dividend Yield

1.64 %

Current Year

+99 939 543 EUR

Last Year

+83 175 568 EUR

Current Quarter

+23 978 030 EUR

Last Quarter

+28 692 649 EUR

Current Year

+61 084 583 EUR

Last Year

+30 087 984 EUR

Current Quarter

+7 106 337 EUR

Last Quarter

+16 117 673 EUR

Key Figures PHN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 23 335 716 EUR
Operating Margin TTM 16.32 %
PE Ratio 48.3036
Return On Assets TTM 11.99 %
PEG Ratio
Return On Equity TTM 19.37 %
Wall Street Target Price 72.41 EUR
Revenue TTM 100 869 103 EUR
Book Value 5.84 EUR
Revenue Per Share TTM
Dividend Share 0.85 EUR
Quarterly Revenue Growth YOY 0.4 %
Dividend Yield 1.64 %
Gross Profit TTM 29 419 739 EUR
Earnings per share 1.12 EUR
Diluted Eps TTM 1.12 EUR
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -43.8 %
Profit Margin 10.71 %

Dividend Analytics PHN

Dividend growth over 5 years

142 %

Continuous growth

5 years

Payout Ratio 5 years average

40 %

Dividend History PHN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.85
Ex Dividend Date 06.05.2024
Forward Annual Dividend Yield 1.64 %
Last Split Factor
Payout Ratio 99.58 %
Last Split Date
Dividend Date

Stock Valuation PHN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 48.3036
Forward PE
Enterprise Value Revenue 4.955
Price Sales TTM 5.1434
Enterprise Value EBITDA 20.2825
Price Book MRQ 8.7188

Financials PHN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PHN

For 52 weeks

42.73 EUR 62.3 EUR
50 Day MA 48.15 EUR
Shares Short Prior Month
200 Day MA 53.37 EUR
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

C

CGRIF

27.90 USD Canadian General Investments Ltd 0 (0%)
Detailed analytics
6

600841

4.05 CNY Shanghai Diesel Engine Co Ltd A +0.05 (+9.76%)
Detailed analytics
D

DOCM

37.50 CHF DocMorris AG -0.19 (-0.42%)
Detailed analytics
7

761

54.50 EUR PHARMANUTRA S.P.A. +1.22 (+2.06%)
Detailed analytics
P

PXI

0.11 EUR SHANDONG MOLONG -H- 0 (0%)
Detailed analytics